DrugPatentWatch Database Preview
PROLIA Drug Profile
Summary for Tradename: PROLIA
| Patents: | 87 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Drug Prices: | Drug price information for PROLIA |
Pharmacology for PROLIA
| Mechanism of Action | RANK Ligand Blocking Activity |
US Patents for PROLIA
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amgen | PROLIA | denosumab | INJECTABLE; SUBCUTANEOUS | 125320 | 001 | 2010-06-01 | See Pricing | OncoMed Pharmaceuticals, Inc. (Redwood City, CA) | 2033-02-04 | RX | Orphan | search |
| Amgen | PROLIA | denosumab | INJECTABLE; SUBCUTANEOUS | 125320 | 001 | 2010-06-01 | See Pricing | CALITOR SCIENCES, LLC (Newbury Park, CA) SUNSHINE LAKE PHARMA CO., LTD. (Dongguan, Guangdong, CN) | 2032-11-14 | RX | Orphan | search |
| Amgen | PROLIA | denosumab | INJECTABLE; SUBCUTANEOUS | 125320 | 001 | 2010-06-01 | See Pricing | UCB PHARMA S.A. (Slough, GB) | 2025-05-03 | RX | Orphan | search |
| Amgen | PROLIA | denosumab | INJECTABLE; SUBCUTANEOUS | 125320 | 001 | 2010-06-01 | See Pricing | ANTECIP BIOVENTURES II LLC (New York, NY) | 2034-06-11 | RX | Orphan | search |
| Amgen | PROLIA | denosumab | INJECTABLE; SUBCUTANEOUS | 125320 | 001 | 2010-06-01 | See Pricing | Calitor Sciences, LLC (Newbury Park, CA) Sunshine Lake Pharma Co., LTD. (Dongguan, Guangdong, CN) | 2035-11-14 | RX | Orphan | search |
| Amgen | PROLIA | denosumab | INJECTABLE; SUBCUTANEOUS | 125320 | 001 | 2010-06-01 | See Pricing | Arena Pharmaceuticals, Inc. (San Diego, CA) | 2038-10-10 | RX | Orphan | search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for PROLIA
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Mexico | 2015004610 | See Pricing |
| Japan | 6043733 | See Pricing |
| Poland | 336311 | See Pricing |
| World Intellectual Property Organization (WIPO) | 2016015597 | See Pricing |
| Japan | 2017109988 | See Pricing |
| Japan | 2009022280 | See Pricing |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for PROLIA
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 122019000070 | Germany | See Pricing | PRODUCT NAME: APREMILAST ODER EIN PHARMAZEUTISCH AKZEPTABLES SALZ DAVON; REGISTRATION NO/DATE: EU/1/14/981 20150115 |
| 91757 | Luxembourg | See Pricing | 91757, EXPIRES: 20250526 |
| SPC/GB10/043 | United Kingdom | See Pricing | PRODUCT NAME: DENOSUMAB, IMMUNOGLOBULIN G2, ANTI-(HUMAN TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 11 (HUMAN OSTEOCLAST DIFFERENTIATION FACTOR))(HUMAN MONOCLONAL AMG 162 HEAVY CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL AMG 162 LIGHT CHAIN, DIMER.; REGISTERED: UK EU/1/10/618/001 20100526; UK EU/1/10/618/002 20100526; UK EU/1/10/618/003 20100526; UK EU/1/10/618/004 20100526 |
| PA2010013,C0975754 | Lithuania | See Pricing | PRODUCT NAME: DENOSUMABUM; REGISTRATION NO/DATE: EU/1/10/618/001, 2010 05 26, EU/1/10/618/002, 2010 05 26, EU/1/10/618/003, 2010 05 26, EU/1/10/618/004 20100526 |
| SZ 44/2010 | Austria | See Pricing | PRODUCT NAME: DENOSUMAB |
| 1090038-9 | Sweden | See Pricing | PERIOD OF VALIDITY (FROM - UNTIL): 20220626 - 20250527 |
| >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
